KLK3 and neoplasm: Pathological Gleason score (GS) and serum prostate-specific antigen (PSA) are mainly applied in outcome prediction for PCa [2] but remain imperfect in predicting properties of the tumor and biochemical recurrence (BCR), which may lead to over-treatment in patients with indolent cancer [3].